Cargando…

MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel

BACKGROUND: In this study, we evaluated the therapeutic effect of MOK, a pharmacopuncture medicine, on thyroid dysfunction in L-thyroxin (LT4)-induced hyperthyroidism rats. METHODS: The experimental hyperthyroidism model was prepared by the intraperitoneal injection of LT4 (0.5 mg/kg) once daily for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Ji Hye, Kang, Seok Yong, Kang, An Na, Jung, Hyo Won, Jung, Chul, Jeong, Jin-Ho, Park, Yong-Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732465/
https://www.ncbi.nlm.nih.gov/pubmed/29246135
http://dx.doi.org/10.1186/s12906-017-2036-1
_version_ 1783286704205987840
author Hwang, Ji Hye
Kang, Seok Yong
Kang, An Na
Jung, Hyo Won
Jung, Chul
Jeong, Jin-Ho
Park, Yong-Ki
author_facet Hwang, Ji Hye
Kang, Seok Yong
Kang, An Na
Jung, Hyo Won
Jung, Chul
Jeong, Jin-Ho
Park, Yong-Ki
author_sort Hwang, Ji Hye
collection PubMed
description BACKGROUND: In this study, we evaluated the therapeutic effect of MOK, a pharmacopuncture medicine, on thyroid dysfunction in L-thyroxin (LT4)-induced hyperthyroidism rats. METHODS: The experimental hyperthyroidism model was prepared by the intraperitoneal injection of LT4 (0.5 mg/kg) once daily for 2 weeks in SD rats. MOK extract was injected at doses of 0.3 or 3 mg/kg on acupuncture points in the thyroid glands of LT4-induced hypothyroidism rats once a day for 2 weeks. The body temperature, body weight, and food/water intake were measured once a week for 2 weeks. The levels of thyroid hormones, total cholesterol, LDL-cholesterol, GOT, and GPT were measured in the sera of rats using ELISA and an automatic blood analyzer. The histological changes of thyroid tissues were observed by H&E staining. The expression of thermo-regulating protein, TRPV1 was determined by western blot in dorsal root ganglion (DRG) and brain tissues. We also measured the contents of GSH in the liver and antioxidant enzymes, SOD, and catalase in the liver, heart, and brain tissues by enzyme-based assay and Western blot, respectively. RESULTS: The acupuncture of MOK extract on the thyroid gland of LT4-induced hyperthyroidism rats significantly decreased the body temperature, and did not change body weight and food and water intakes. MOK acupuncture significantly increased the level of TSH, and decreased the levels of T3 and T4 in hyperthyroidism rats. The expression of TRPV1 was inhibited in both DRG and brain tissues after MOK acupuncture, and the levels of GOT, GPT, total cholesterol, and LDL-cholesterol were also decreased. MOK acupuncture also inhibited the pathological feature with follicular lining epithelial thicknesses and increased follicular colloid depositions in the thyroid glands of hypothyroidism. MOK acupuncture significantly increased hepatic GSH levels and decreased the expression of SOD and catalase in the liver, heart, and brain tissues of hyperthyroidism rats. CONCLUSIONS: These results suggest that the pharmacopuncture with MOK extract in hyperthyroidism can improve the pathophysiological changes through regulating the body temperature, thyroid hormones imbalance, lipid accumulation, and oxidation. This anti-hyperthyroidism effect of MOK pharmacopuncture is thought to be related to the control of thermo-regulating protein TRPV1 in DRG and brain.
format Online
Article
Text
id pubmed-5732465
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57324652017-12-21 MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel Hwang, Ji Hye Kang, Seok Yong Kang, An Na Jung, Hyo Won Jung, Chul Jeong, Jin-Ho Park, Yong-Ki BMC Complement Altern Med Research Article BACKGROUND: In this study, we evaluated the therapeutic effect of MOK, a pharmacopuncture medicine, on thyroid dysfunction in L-thyroxin (LT4)-induced hyperthyroidism rats. METHODS: The experimental hyperthyroidism model was prepared by the intraperitoneal injection of LT4 (0.5 mg/kg) once daily for 2 weeks in SD rats. MOK extract was injected at doses of 0.3 or 3 mg/kg on acupuncture points in the thyroid glands of LT4-induced hypothyroidism rats once a day for 2 weeks. The body temperature, body weight, and food/water intake were measured once a week for 2 weeks. The levels of thyroid hormones, total cholesterol, LDL-cholesterol, GOT, and GPT were measured in the sera of rats using ELISA and an automatic blood analyzer. The histological changes of thyroid tissues were observed by H&E staining. The expression of thermo-regulating protein, TRPV1 was determined by western blot in dorsal root ganglion (DRG) and brain tissues. We also measured the contents of GSH in the liver and antioxidant enzymes, SOD, and catalase in the liver, heart, and brain tissues by enzyme-based assay and Western blot, respectively. RESULTS: The acupuncture of MOK extract on the thyroid gland of LT4-induced hyperthyroidism rats significantly decreased the body temperature, and did not change body weight and food and water intakes. MOK acupuncture significantly increased the level of TSH, and decreased the levels of T3 and T4 in hyperthyroidism rats. The expression of TRPV1 was inhibited in both DRG and brain tissues after MOK acupuncture, and the levels of GOT, GPT, total cholesterol, and LDL-cholesterol were also decreased. MOK acupuncture also inhibited the pathological feature with follicular lining epithelial thicknesses and increased follicular colloid depositions in the thyroid glands of hypothyroidism. MOK acupuncture significantly increased hepatic GSH levels and decreased the expression of SOD and catalase in the liver, heart, and brain tissues of hyperthyroidism rats. CONCLUSIONS: These results suggest that the pharmacopuncture with MOK extract in hyperthyroidism can improve the pathophysiological changes through regulating the body temperature, thyroid hormones imbalance, lipid accumulation, and oxidation. This anti-hyperthyroidism effect of MOK pharmacopuncture is thought to be related to the control of thermo-regulating protein TRPV1 in DRG and brain. BioMed Central 2017-12-15 /pmc/articles/PMC5732465/ /pubmed/29246135 http://dx.doi.org/10.1186/s12906-017-2036-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hwang, Ji Hye
Kang, Seok Yong
Kang, An Na
Jung, Hyo Won
Jung, Chul
Jeong, Jin-Ho
Park, Yong-Ki
MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel
title MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel
title_full MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel
title_fullStr MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel
title_full_unstemmed MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel
title_short MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel
title_sort mok, a pharmacopuncture medicine, regulates thyroid dysfunction in l-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the trpv1 ion channel
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732465/
https://www.ncbi.nlm.nih.gov/pubmed/29246135
http://dx.doi.org/10.1186/s12906-017-2036-1
work_keys_str_mv AT hwangjihye mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel
AT kangseokyong mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel
AT kanganna mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel
AT junghyowon mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel
AT jungchul mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel
AT jeongjinho mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel
AT parkyongki mokapharmacopuncturemedicineregulatesthyroiddysfunctioninlthyroxininducedhyperthyroidisminratsthroughtheregulationofoxidationandthetrpv1ionchannel